Main menu


Accenture Releases Life Science Technology Vision 2022 Report

NEW YORK, August 22, 2022 — Accenture’s Life Sciences Technology Vision 2022 report helps biopharmaceutical and medical technology companies solve manufacturing and device challenges, improve equity in clinical trial participation, and become more resilient. Explore the technology trends that are transforming how we build and deliver global supply chains to patients. Healthcare professionals providing a more personalized experience.

The Metaverse is an evolving and expanding continuum in multiple dimensions, digital and physical, including technologies such as augmented reality, blockchain, artificial intelligence, digital twins, non-fungible tokens, and smart devices. According to the report, life sciences leaders (91% of medtech executives and 85% of biopharmaceutical executives) expect the metaverse to have a positive impact on their organizations, Nearly half of pharma executives believe the metaverse will have a breakthrough or transformative impact. about their organization.

Petra Janzer, Global Industry Life Sciences Leader, Accenture, said: Fundamentally running an organization is a building block of the future of life sciences. Industry leaders are pioneering a new digital future for how people and businesses interact, but many of the rules remain undefined. It is critical that life sciences companies take steps to shape the metaverse continuum proactively and responsibly. ”

Accenture recently launched the Accenture Metaverse Continuum Business Group to help life sciences companies design, execute and accelerate their metaverse journeys. artificial intelligence, computer vision.

This report examines four technology trends that underpin the metaverse continuum.

  • web me shows how the Internet is being reimagined using the Metaverse as a platform for digital experiences that offer limitless places where people can meet and interact. Web3 is reinventing how individuals own their data and it travels with them, not the platform. In the future, a new generation of digital devices will be integrated into the metaverse, including smart technology in everyday items such as home appliances, “smart” cars that provide salient data on healthy human behavior, and medically regulated devices such as the Donisi. Multiple biological parameters can be detected and analyzed simultaneously.
  • programmable world It tracks how technology moves through our physical environment at three layers: connections, experiences, and materials. Nearly nine of his ten MedTech and biopharmaceutical executives surveyed believe that programming the physical environment will be a competitive differentiator for the industry. Augmented reality, 5G, ambient computing, 3D printing and smart materials are merging in sophisticated ways to make the physical world as smart, customizable and programmable as the digital world.
  • Unreal Exploring the “unrealistic” nature that is becoming the foundation of artificial intelligence (AI) and data, making artifacts look real. Synthetic data is being used to train AI models in ways that real-world data cannot or should not actually do. Synthetic data can represent patient datasets for use in research, training, or other applications. You can share this real (yet unreal) data while preserving confidentiality and privacy while maintaining the same statistical properties. It overcomes the pitfalls of real-world data as it can be developed to accommodate increased diversity to combat bias. More than nine-tenths of his executives at biopharmaceutical companies (92%) and medical technology companies (91%) report that their organizations rely on AI technology to function effectively.
  • calculate the impossible The emergence of a new class of machines that pushes the boundaries of what computers can do: quantum computing. Problems once thought unsolvable are now entering the realm of possibility as large and complex data sets need to be computed. Nearly all surveyed biopharmaceutical (94%) and medtech (96%) executives say their organizations are reorienting in response to unprecedented computing power becoming available I agree with you.

The Life Sciences Technology Vision 2022 report can be accessed here.

About Accenture

Accenture is a global professional services firm with strong capabilities in digital, cloud and security. Combining unparalleled experience and specialized skills in over 40 industries, Strategy and Consulting, Technology and Operations Services, Accenture delivers his song. All of this is underpinned by advanced technology and the world’s largest network of intelligent operations centers. Our 710,000 employees serve clients in over 120 countries and deliver on the promise of technology and human ingenuity every day. We harness the power of change to create value and share our success for our clients, employees, shareholders, partners and communities.

Source: Accenture